During the past decade, Clinique Pasteur conducted 151 clinical trials. In the 10-year time frame, 151 clinical trials started and 40 clinical trials were completed, i.e. on average, 26.5% percent of trials that started reached the finish line to date. In the past 5 years, 69 clinical trials started and 24 clinical trials were completed. i.e. 34.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique Pasteur" #1 sponsor was "Boston Scientific Corporation" with 21 trials, followed by "Hoffmann-La Roche" with 15 trials sponsored, "Abbott Medical Devices" with 13 trials sponsored, "Clinique Pasteur" with 11 trials sponsored and "UNICANCER" with 11 trials sponsored. Other sponsors include 171 different institutions and companies that sponsored additional 118 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique Pasteur" #1 collaborator was "Boston Scientific Corporation" with 5 trials as a collaborator, "Medtronic" with 5 trials as a collaborator, "University Hospital, Grenoble" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator. Other collaborators include 100 different institutions and companies that were collaborators in the rest 98 trials.

According to Clinical.Site data, the most researched conditions in "Clinique Pasteur" are "Coronary Artery Disease" (27 trials), "Atrial Fibrillation" (18 trials), "Aortic Valve Stenosis" (14 trials), "Breast Cancer" (13 trials) and "Heart Failure" (11 trials). Many other conditions were trialed in "Clinique Pasteur" in a lesser frequency.

Most popular intervention types in "Clinique Pasteur" are "Device" (130 trials), "Drug" (65 trials), "Procedure" (24 trials), "Other" (23 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Trastuzumab" (7 trials), "Bevacizumab" (6 trials), "Docetaxel" (5 trials) and "Pertuzumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Pasteur" are 208 trials for "All" genders, 24 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Clinique Pasteur". 3 are not yet recruiting, 43 are recruiting, 37 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 127 completed trials in Clinique Pasteur, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Pasteur, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 103 trials that are defined as “Not Applicable".